{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:36:42Z","timestamp":1791020202504,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.parkreldis.2024.106982","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T15:47:32Z","timestamp":1714751252000},"page":"106982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Consensus practice recommendations for management of gastrointestinal dysfunction in Parkinson disease"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2625-2049","authenticated-orcid":false,"given":"Delaram","family":"Safarpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natividad","family":"Stover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Shprecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali G.","family":"Hamedani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald F.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry P.","family":"Parkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamonn MM.","family":"Quigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie J.","family":"Cloud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.parkreldis.2024.106982_bib1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","article-title":"Gastrointestinal dysfunction in Parkinson's disease","volume":"14","author":"Fasano","year":"2015","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.106982_bib2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mds.27602","article-title":"Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review","volume":"34","author":"Seppi","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2024.106982_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/JHL.S352500","article-title":"An adaptation of the RAND\/UCLA modified Delphi panel method in the time of COVID-19","volume":"14","author":"Broder","year":"2022","journal-title":"J. Healthc. Leader"},{"issue":"11","key":"10.1016\/j.parkreldis.2024.106982_bib4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.parkreldis.2014.08.013","article-title":"Drooling in Parkinson's disease: a review","volume":"20","author":"Srivanitchapoom","year":"2014","journal-title":"Park. Relat. Disord."},{"issue":"5","key":"10.1016\/j.parkreldis.2024.106982_bib5","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/mds.20784","article-title":"Quantitative study of salivary secretion in Parkinson's disease","volume":"21","author":"Tumilasci","year":"2006","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106982_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.parkreldis.2010.08.003","article-title":"Gastrointestinal dysfunction in Parkinson's disease","volume":"17","author":"Pfeiffer","year":"2011","journal-title":"Park. Relat. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2024.106982_bib7","article-title":"Predictive clinical factors for penetration and aspiration in Parkinson's disease","volume":"31","author":"Nienstedt","year":"2018","journal-title":"Neuro Gastroenterol. Motil. : Off. J. Eur. Gastrointest.Motility Soc."},{"issue":"4","key":"10.1016\/j.parkreldis.2024.106982_bib8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11910-011-0204-0","article-title":"Gastrointestinal features of Parkinson's disease","volume":"11","author":"Cloud","year":"2011","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"12","key":"10.1016\/j.parkreldis.2024.106982_bib9","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/mds.28248","article-title":"Helicobacter pylori eradication in Parkinson's disease: a randomized placebo-controlled trial","volume":"35","author":"Tan","year":"2020","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.parkreldis.2024.106982_bib10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection--the maastricht IV\/florence consensus report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.parkreldis.2024.106982_bib11","first-page":"Cd011194","article-title":"Proton pump inhibitors for functional dyspepsia","volume":"11","author":"Pinto-Sanchez","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.parkreldis.2024.106982_bib12","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.46.4.1051","article-title":"Gastric emptying in Parkinson's disease: patients with and without response fluctuations","volume":"46","author":"Djaldetti","year":"1996","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.parkreldis.2024.106982_bib13","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.38.3.419","article-title":"Erratic gastric emptying of levodopa may cause \u201crandom\u201d fluctuations of parkinsonian mobility","volume":"38","author":"Kurlan","year":"1988","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.parkreldis.2024.106982_bib14","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3109\/00365529108998623","article-title":"Scintigraphic determination of gastrointestinal transit times. A comparison with breath hydrogen and radiologic methods","volume":"26","author":"Madsen","year":"1991","journal-title":"Scand. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.106982_bib15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.gtc.2021.02.008","article-title":"Small intestinal bacterial overgrowth","volume":"50","author":"Bushyhead","year":"2021","journal-title":"Gastroenterol. Clin. N. Am."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.106982_bib16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.5858\/134.2.264","article-title":"Small intestinal bacterial overgrowth: histopathologic features and clinical correlates in an underrecognized entity","volume":"134","author":"Lappinga","year":"2010","journal-title":"Arch. Pathol. Lab Med."},{"issue":"9","key":"10.1016\/j.parkreldis.2024.106982_bib17","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/mds.25522","article-title":"The role of small intestinal bacterial overgrowth in Parkinson's disease","volume":"28","author":"Fasano","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2024.106982_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.parkreldis.2018.04.003","article-title":"Small intestinal bacterial overgrowth in Parkinson's disease: tribulations of a trial","volume":"54","author":"Vizcarra","year":"2018","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"12","key":"10.1016\/j.parkreldis.2024.106982_bib19","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1080\/17474124.2021.2005579","article-title":"Efficacy of rifaximin in treating with small intestine bacterial overgrowth: a systematic review and meta-analysis","volume":"15","author":"Wang","year":"2021","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.parkreldis.2024.106982_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000103892","article-title":"Small intestinal bacterial overgrowth: diagnosis and treatment","volume":"25","author":"Gasbarrini","year":"2007","journal-title":"Dig. Dis."},{"issue":"5","key":"10.1016\/j.parkreldis.2024.106982_bib21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.13928","article-title":"Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth","volume":"45","author":"Gatta","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.parkreldis.2024.106982_bib22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MCG.0000000000000814","article-title":"Probiotics for preventing and treating small intestinal bacterial overgrowth: a meta-analysis and systematic review of current evidence","volume":"51","author":"Zhong","year":"2017","journal-title":"J. Clin. Gastroenterol."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106982_bib23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ajg.2016.472","article-title":"Irritable bowel syndrome-like symptoms following fecal microbiota transplantation: a possible donor-dependent complication","volume":"112","author":"Chang","year":"2017","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106982_bib24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12876-021-01630-x","article-title":"Clinical efficacy of fecal microbiota transplantation for patients with small intestinal bacterial overgrowth: a randomized, placebo-controlled clinic study","volume":"21","author":"Xu","year":"2021","journal-title":"BMC Gastroenterol."},{"issue":"4","key":"10.1016\/j.parkreldis.2024.106982_bib25","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1212\/WNL.42.4.726","article-title":"Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology","volume":"42","author":"Edwards","year":"1992","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106982_bib26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/mds.26866","article-title":"Constipation in Parkinson's disease: subjective symptoms, objective markers, and new perspectives","volume":"32","author":"Knudsen","year":"2017","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.parkreldis.2024.106982_bib27","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/mds.26431","article-title":"MDS research criteria for prodromal Parkinson's disease","volume":"30","author":"Berg","year":"2015","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.parkreldis.2024.106982_bib28","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1093\/brain\/awz111","article-title":"Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study","volume":"142","author":"Fereshtehnejad","year":"2019","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.parkreldis.2024.106982_bib29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2036.2006.03238.x","article-title":"Chronic constipation: a survey of the patient perspective","volume":"25","author":"Johanson","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.parkreldis.2024.106982_bib30","article-title":"Bowel disorders","author":"Mearin","year":"2016","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.parkreldis.2024.106982_bib31","first-page":"332","article-title":"Clinical Practice Guideline: irritable bowel syndrome with constipation and functional constipation in the adult","volume":"108","author":"Mearin","year":"2016","journal-title":"Rev. Esp. Enferm. Dig."},{"issue":"12","key":"10.1016\/j.parkreldis.2024.106982_bib32","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.7326\/M22-1438","article-title":"Oral ENT-01 targets enteric neurons to treat constipation in Parkinson disease : a randomized controlled trial","volume":"175","author":"Camilleri","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.parkreldis.2024.106982_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1046910","article-title":"A review of studies on gut microbiota and levodopa metabolism","volume":"14","author":"Zhong","year":"2023","journal-title":"Front. Neurol."},{"issue":"7","key":"10.1016\/j.parkreldis.2024.106982_bib34","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1136\/gut.28.7.864","article-title":"Modulation of human upper gastrointestinal motility by rectal distension","volume":"28","author":"Kellow","year":"1987","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.parkreldis.2024.106982_bib35","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1055\/s-0043-1771457","article-title":"Constipation in Parkinson's disease","volume":"43","author":"Quigley","year":"2023","journal-title":"Semin. Neurol."},{"issue":"10","key":"10.1016\/j.parkreldis.2024.106982_bib36","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/mds.29176","article-title":"Gastrointestinal motility and response to levodopa in Parkinson's disease: a proof-of-concept study","volume":"37","author":"Safarpour","year":"2022","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.parkreldis.2024.106982_bib37","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.purol.2014.06.008","article-title":"[Bristol Stool Chart: prospective and monocentric study of \"stools introspection\" in healthy subjects]","volume":"24","author":"Amarenco","year":"2014","journal-title":"Prog. Urol."},{"issue":"11","key":"10.1016\/j.parkreldis.2024.106982_bib38","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3748\/wjg.v27.i11.1055","article-title":"Study on the characteristics of intestinal motility of constipation in patients with Parkinson's disease","volume":"27","author":"Zhang","year":"2021","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.parkreldis.2024.106982_bib39","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/mdc3.13755","article-title":"Differential findings on anorectal manometry in patients with Parkinson's disease and defecatory dysfunction","volume":"10","author":"Zhou","year":"2023","journal-title":"Mov Disord Clin Pract"},{"issue":"6","key":"10.1016\/j.parkreldis.2024.106982_bib40","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1053\/j.gastro.2022.08.034","article-title":"Comparison of anorectal manometry, rectal balloon expulsion test, and defecography for diagnosing defecatory disorders","volume":"163","author":"Blackett","year":"2022","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106982_bib41","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/nau.21218","article-title":"Rectal balloon training as add-on therapy to pelvic floor muscle training in adults with fecal incontinence: a randomized controlled trial","volume":"31","author":"Bols","year":"2012","journal-title":"Neurourol. Urodyn."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106982_bib42","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-0040-1714287","article-title":"Biofeedback for pelvic floor disorders","volume":"34","author":"Hite","year":"2021","journal-title":"Clin. Colon Rectal Surg."},{"issue":"44","key":"10.1016\/j.parkreldis.2024.106982_bib43","doi-asserted-by":"crossref","first-page":"7069","DOI":"10.3748\/wjg.v12.i44.7069","article-title":"Biofeedback therapy for dyssynergic defecation","volume":"12","author":"Chiarioni","year":"2006","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.parkreldis.2024.106982_bib44","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.410330512","article-title":"Defecatory function in Parkinson's disease: response to apomorphine","volume":"33","author":"Edwards","year":"1993","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.parkreldis.2024.106982_bib45","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1365-2036.2005.02669.x","article-title":"Outlet type constipation in Parkinson's disease: results of botulinum toxin treatment","volume":"22","author":"Cadeddu","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.parkreldis.2024.106982_bib46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.parkreldis.2017.08.020","article-title":"Pilot cohort study of endoscopic botulinum neurotoxin injection in Parkinson's disease","volume":"44","author":"Triadafilopoulos","year":"2017","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"6","key":"10.1016\/j.parkreldis.2024.106982_bib47","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/jn\/125.6.1401","article-title":"Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics","volume":"125","author":"Gibson","year":"1995","journal-title":"J. Nutr."},{"issue":"8","key":"10.1016\/j.parkreldis.2024.106982_bib48","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document: the international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.parkreldis.2024.106982_bib49","article-title":"Efficacy and safety of probiotics in Parkinson's constipation: a systematic review and meta-analysis","volume":"13","author":"Xie","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.106982_bib50","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cgh.2018.09.028","article-title":"Prebiotics and probiotics in digestive health","volume":"17","author":"Quigley","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.106982_bib51","first-page":"274","article-title":"Effects of resistant starch on symptoms, fecal markers, and gut microbiota in Parkinson's disease - the RESISTA-PD trial","volume":"20","author":"Becker","year":"2022","journal-title":"Dev. Reprod. Biol."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106982_bib52","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/s41467-023-36497-x","article-title":"An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson's disease participants","volume":"14","author":"Hall","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.106982_bib53","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2284247","article-title":"Efficacy of fecal microbiota transplantation in patients with Parkinson's disease: clinical trial results from a randomized, placebo-controlled design","volume":"15","author":"Cheng","year":"2023","journal-title":"Gut Microb."},{"issue":"9","key":"10.1016\/j.parkreldis.2024.106982_bib54","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/j.1572-0241.2007.01365.x","article-title":"A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation","volume":"102","author":"Di Palma","year":"2007","journal-title":"Am. J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.parkreldis.2024.106982_bib55","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/mds.21243","article-title":"Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study","volume":"22","author":"Zangaglia","year":"2007","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106982_bib56","first-page":"19","article-title":"Comparison of pyridostigmine and bisacodyl in the treatment of refractory chronic constipation","volume":"7","author":"Soufi-Afshar","year":"2016","journal-title":"Caspian J. Intern. Med."},{"issue":"11","key":"10.1016\/j.parkreldis.2024.106982_bib57","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1177\/1756283X17734809","article-title":"An update on prucalopride in the treatment of chronic constipation","volume":"10","author":"Omer","year":"2017","journal-title":"Therap. Adv. Gastroenterol."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.106982_bib58","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1053\/gast.2001.21166","article-title":"Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder","volume":"120","author":"Bouras","year":"2001","journal-title":"Gastroenterology"},{"issue":"16","key":"10.1016\/j.parkreldis.2024.106982_bib59","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1517\/14656566.2015.1086747","article-title":"The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson's disease","volume":"16","author":"Barboza","year":"2015","journal-title":"Expet Opin. Pharmacother."},{"issue":"21","key":"10.1016\/j.parkreldis.2024.106982_bib60","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1212\/WNL.0b013e3182574f28","article-title":"Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease","volume":"78","author":"Ondo","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.parkreldis.2024.106982_bib61","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/mdc3.12577","article-title":"Linaclotide and prucalopride for management of constipation in patients with parkinsonism","volume":"5","author":"Freitas","year":"2018","journal-title":"Mov Disord Clin Pract"},{"issue":"3","key":"10.1016\/j.parkreldis.2024.106982_bib62","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.gtc.2009.06.001","article-title":"Chronic constipation in the elderly","volume":"38","author":"Bouras","year":"2009","journal-title":"Gastroenterol. Clin. N. Am."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106982_bib63","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2036.2007.03354.x","article-title":"Systematic review: the adverse effects of sodium phosphate enema","volume":"26","author":"Mendoza","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.parkreldis.2024.106982_bib64","doi-asserted-by":"crossref","first-page":"271","DOI":"10.5056\/jnm23066","article-title":"Seoul consensus on clinical practice guidelines for functional constipation","volume":"29","author":"Cho","year":"2022","journal-title":"J. Neurogastroenterol. Motil."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106982_bib65","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bpg.2011.01.004","article-title":"Biofeedback therapy for constipation in adults","volume":"25","author":"Rao","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"3","key":"10.1016\/j.parkreldis.2024.106982_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.gtc.2008.06.011","article-title":"Dyssynergic defecation and biofeedback therapy","volume":"37","author":"Rao","year":"2008","journal-title":"Gastroenterol. Clin. N. Am."},{"issue":"11","key":"10.1016\/j.parkreldis.2024.106982_bib67","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1023\/A:1018846113210","article-title":"Effects of biofeedback therapy on anorectal function in obstructive defecation","volume":"42","author":"Rao","year":"1997","journal-title":"Dig. Dis. Sci."},{"issue":"s2","key":"10.1016\/j.parkreldis.2024.106982_bib68","doi-asserted-by":"crossref","first-page":"S371","DOI":"10.3233\/JPD-191802","article-title":"Faecal transplantation, pro- and prebiotics in Parkinson's disease; hope or hype?","volume":"9","author":"Van Laar","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.parkreldis.2024.106982_bib69","doi-asserted-by":"crossref","first-page":"40","DOI":"10.21037\/tgh.2019.05.10","article-title":"Fecal microbiota transplantation: great potential with many challenges","volume":"4","author":"Kellermayer","year":"2019","journal-title":"Transl. Gastroenterol. Hepatol."},{"issue":"15","key":"10.1016\/j.parkreldis.2024.106982_bib70","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/mds.21730","article-title":"Ipratropium bromide spray as treatment for sialorrhea in Parkinson's disease","volume":"22","author":"Thomsen","year":"2007","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.parkreldis.2024.106982_bib71","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/mds.10276","article-title":"Sublingual Atropine for sialorrhea secondary to parkinsonism: a pilot study","volume":"17","author":"Hyson","year":"2002","journal-title":"Mov. Disord."},{"issue":"15","key":"10.1016\/j.parkreldis.2024.106982_bib72","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/WNL.0b013e3181d8c1b7","article-title":"Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial","volume":"74","author":"Arbouw","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2024.106982_bib73","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1212\/01.WNL.0000101713.81253.4C","article-title":"A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease","volume":"62","author":"Ondo","year":"2004","journal-title":"Neurology"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802024009945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802024009945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T16:28:22Z","timestamp":1719851302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802024009945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":73,"alternative-id":["S1353802024009945"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106982","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consensus practice recommendations for management of gastrointestinal dysfunction in Parkinson disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106982","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106982"}}